Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Venture Life ( (GB:VLG) ) is now available.
Venture Life Group has continued its previously announced share buyback programme, repurchasing 155,128 ordinary shares at a volume-weighted average price of 67.95 pence per share via Cavendish Capital Markets. The shares will be held in treasury, leaving 128,860,145 ordinary shares in issue, of which 6,689,952 are in treasury, and setting the company’s total voting rights at 122,170,193 for shareholder disclosure calculations.
The latest buyback incrementally reduces the free float and may support earnings per share over time, while clarifying the new voting rights denominator for investors subject to the FCA’s Disclosure Guidance and Transparency Rules. The move underlines management’s ongoing capital management strategy and signals continued confidence in the group’s valuation and long-term prospects within the consumer healthcare space.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £67.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Spark’s Take on VLG Stock
According to Spark, TipRanks’ AI Analyst, VLG is a Neutral.
Venture Life’s stock score is primarily supported by strong technical indicators and positive corporate events, such as share buybacks and insider buying, which suggest confidence in future prospects. However, the high P/E ratio and profitability challenges weigh down the score, indicating potential overvaluation and financial risks.
To see Spark’s full report on VLG stock, click here.
More about Venture Life
Venture Life Group is a UK-headquartered international consumer self-care company operating in the global consumer healthcare sector. Its portfolio spans women’s intimate healthcare, ENT care, energy and glucose management, and products supporting the hormonal lifecycle, sold via pharmacies, health and beauty retailers, grocery chains, and e-commerce, both directly and through international distributors.
Average Trading Volume: 305,956
Technical Sentiment Signal: Buy
Current Market Cap: £83.18M
For a thorough assessment of VLG stock, go to TipRanks’ Stock Analysis page.